NAPROXEN SODIUM

NAPROXEN SODIUM was reported 143529 times

NAPROXEN SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 248 0.7381
1 CARDIOSPASM 401 0.7186
2 IMMUNISATION 258 0.5945
3 GRIP STRENGTH 129 0.5633
4 C-REACTIVE PROTEIN 521 0.5620
5 PALMOPLANTAR KERATODERMA 388 0.5352
6 CONGENITAL HIATUS HERNIA 122 0.5351
7 FACET JOINT SYNDROME 1730 0.5308
8 SWOLLEN JOINT COUNT 131 0.5240
9 LUPUS VULGARIS 656 0.5206
10 DEEP VEIN THROMBOSIS POSTOPERATIVE 1019 0.5087
11 SWOLLEN JOINT COUNT INCREASED 1534 0.4806
12 RHEUMATIC FEVER 2131 0.4776
13 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 311 0.4656
14 DISLOCATION OF VERTEBRA 1010 0.4424
15 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 911 0.4392
16 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 243 0.4332
17 HYPOCHOLESTEROLAEMIA 149 0.4221
18 RED BLOOD CELL SEDIMENTATION RATE 117 0.4194
19 BODY HEIGHT BELOW NORMAL 254 0.3950
20 X-RAY ABNORMAL 678 0.3788
21 C-REACTIVE PROTEIN ABNORMAL 2319 0.3612
22 DUODENAL ULCER PERFORATION 2628 0.3530
23 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 2498 0.3483
24 JOINT LAXITY 103 0.3411
25 RHEUMATOID FACTOR POSITIVE 1894 0.3276
26 PERIPHERAL VENOUS DISEASE 1308 0.3200
27 SERONEGATIVE ARTHRITIS 344 0.3002
28 RETINITIS 461 0.2666
29 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 600 0.2602
30 HELICOBACTER INFECTION 2600 0.2527
31 MUSCLE INJURY 2095 0.2526
32 FOLLICULITIS 2519 0.2400
33 SYNOVITIS 4267 0.2364
34 PEMPHIGUS 2868 0.2292
35 BREAST CANCER STAGE III 1452 0.2240
36 HAND DEFORMITY 2934 0.2235
37 PORPHYRIA ACUTE 315 0.2195
38 JOINT DESTRUCTION 323 0.2076
39 LIP DRY 1771 0.1948
40 ONYCHOMADESIS 817 0.1945
41 ATRIAL TACHYCARDIA 406 0.1931
42 GRANULOMA SKIN 157 0.1912
43 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1241 0.1909
44 JOINT RANGE OF MOTION DECREASED 2462 0.1834
45 TENOSYNOVITIS STENOSANS 102 0.1831
46 PERICARDITIS 3064 0.1822
47 PRURITUS GENITAL 419 0.1778
48 BLEPHAROSPASM 1118 0.1774
49 GRIP STRENGTH DECREASED 1558 0.1768
50 WOUND INFECTION 1822 0.1662
51 ENTHESOPATHY 256 0.1636
52 BURSITIS 1961 0.1615
53 BONE EROSION 570 0.1610
54 DRUG TOLERANCE DECREASED 444 0.1580
55 HYPERCHOLESTEROLAEMIA 1522 0.1575
56 RHEUMATOID NODULE 415 0.1505
57 OVERLAP SYNDROME 105 0.1500
58 JUVENILE IDIOPATHIC ARTHRITIS 360 0.1471
59 FIBROMYALGIA 3468 0.1425
60 ONYCHOMYCOSIS 625 0.1423
61 GLOSSODYNIA 3110 0.1388
62 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 104 0.1303
63 ANTIBODY TEST POSITIVE 216 0.1300
64 IRRITABLE BOWEL SYNDROME 2690 0.1253
65 FINGER DEFORMITY 607 0.1252
66 BLOOD PARATHYROID HORMONE DECREASED 175 0.1180
67 OBESITY 1863 0.1168
68 LIVE BIRTH 978 0.1168
69 CAROTID ARTERY OCCLUSION 418 0.1145
70 POLYARTHRITIS 583 0.1105
71 DACTYLITIS 108 0.1100
72 RHEUMATOID LUNG 102 0.1068
73 TENSION HEADACHE 458 0.1064
74 WOUND 2973 0.1063
75 AUTOIMMUNE DISORDER 1031 0.1057
76 PSORIATIC ARTHROPATHY 4191 0.1032
77 NAIL DISORDER 902 0.1030
78 BLOOD PRESSURE DIASTOLIC ABNORMAL 262 0.1029
79 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1128 0.1018
80 INFUSION SITE REACTION 302 0.1010
81 SLEEP TERROR 419 0.0994
82 SACROILIITIS 185 0.0979
83 LIVER INJURY 2384 0.0970
84 SCIATICA 1542 0.0966
85 CONTRAINDICATED PRODUCT ADMINISTERED 2919 0.0963
86 BLOOD PRESSURE SYSTOLIC ABNORMAL 237 0.0958
87 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 100 0.0942
88 IMPAIRED HEALING 3070 0.0934
89 TENOSYNOVITIS 255 0.0924
90 ULCER HAEMORRHAGE 625 0.0923
91 DRUG TOLERANCE 465 0.0918
92 TYPE 2 DIABETES MELLITUS 3071 0.0911
93 ANKYLOSING SPONDYLITIS 1200 0.0910
94 SYSTEMIC LUPUS ERYTHEMATOSUS 3147 0.0886
95 DRUG SPECIFIC ANTIBODY 120 0.0876
96 REBOUND ACID HYPERSECRETION 256 0.0845
97 EXOSTOSIS 765 0.0837
98 PUSTULAR PSORIASIS 284 0.0826
99 BACK INJURY 899 0.0826
100 HYPERPARATHYROIDISM SECONDARY 202 0.0805
101 WALKING AID USER 530 0.0803
102 OESOPHAGEAL SPASM 141 0.0765
103 FOOT DEFORMITY 829 0.0747
104 PULMONARY FIBROSIS 1431 0.0745
105 C-REACTIVE PROTEIN INCREASED 2707 0.0743
106 ARTHROPATHY 4086 0.0734
107 NEPHROGENIC ANAEMIA 340 0.0733
108 PRODUCT LABEL CONFUSION 423 0.0725
109 PANNICULITIS 175 0.0723
110 PRESCRIBED OVERDOSE 1360 0.0702
111 OSTEOARTHRITIS 2787 0.0657
112 GAIT INABILITY 2184 0.0653
113 LOWER LIMB FRACTURE 1221 0.0635
114 LOWER RESPIRATORY TRACT INFECTION 2858 0.0628
115 RASH VESICULAR 303 0.0626
116 INCORRECT DOSAGE ADMINISTERED 304 0.0621
117 SPONDYLITIS 224 0.0615
118 MATERNAL EXPOSURE TIMING UNSPECIFIED 229 0.0609
119 NIGHT SWEATS 1952 0.0605
120 BLOOD CHOLESTEROL INCREASED 2748 0.0589
121 THERAPEUTIC PRODUCT EFFECT DECREASED 2585 0.0577
122 HIP ARTHROPLASTY 878 0.0573
123 EYE INJURY 174 0.0572
124 INFLAMMATION 2901 0.0562
125 BREAST CANCER STAGE II 465 0.0558
126 LUPUS-LIKE SYNDROME 506 0.0557
127 GASTRIC ULCER HAEMORRHAGE 309 0.0557
128 FACIAL PAIN 496 0.0555
129 INFUSION RELATED REACTION 3659 0.0551
130 TASTE DISORDER 1118 0.0551
131 PLEURITIC PAIN 152 0.0550
132 MUSCULOSKELETAL STIFFNESS 4812 0.0549
133 WHEEZING 3208 0.0540
134 ALANINE AMINOTRANSFERASE ABNORMAL 114 0.0540
135 RHEUMATOID ARTHRITIS 6110 0.0538
136 CONGENITAL ANOMALY 412 0.0532
137 DUODENAL ULCER HAEMORRHAGE 152 0.0531
138 MOBILITY DECREASED 3749 0.0521
139 JOINT SWELLING 6269 0.0519
140 INCORRECT DRUG ADMINISTRATION DURATION 1457 0.0518
141 BLISTER 2901 0.0516
142 WHEELCHAIR USER 227 0.0510
143 JOINT EFFUSION 352 0.0510
144 COELIAC DISEASE 498 0.0507
145 DUODENAL ULCER 357 0.0506
146 MUSCULOSKELETAL PAIN 2635 0.0502
147 PRESCRIBED UNDERDOSE 997 0.0499
148 DRUG INTOLERANCE 4763 0.0493
149 JOINT DISLOCATION 517 0.0489
150 LIVER FUNCTION TEST INCREASED 1023 0.0476
151 STOMATITIS 2887 0.0476
152 HEPATIC ENZYME INCREASED 3218 0.0472
153 INJURY 3318 0.0472
154 PRE-EXISTING CONDITION IMPROVED 288 0.0461
155 ADRENAL INSUFFICIENCY 559 0.0460
156 OESOPHAGEAL PAIN 180 0.0455
157 SWELLING 4260 0.0455
158 DISCOMFORT 2767 0.0453
159 SUBARACHNOID HAEMORRHAGE 458 0.0449
160 SYNOVIAL CYST 207 0.0448
161 GASTRIC ULCER 838 0.0440
162 ANTINUCLEAR ANTIBODY POSITIVE 143 0.0440
163 GASTROINTESTINAL ULCER 97 0.0437
164 IRITIS 132 0.0434
165 EXPIRED PRODUCT ADMINISTERED 1406 0.0423
166 VASCULITIS 492 0.0422
167 KNEE ARTHROPLASTY 885 0.0420
168 ULCER 659 0.0414
169 CHOLECYSTITIS CHRONIC 277 0.0413
170 LUNG DISORDER 1991 0.0406
171 OEDEMA 2203 0.0406
172 GASTRIC HAEMORRHAGE 465 0.0404
173 CHRONIC KIDNEY DISEASE 3050 0.0401
174 NECK PAIN 2243 0.0401
175 BLOOD PRESSURE DIASTOLIC INCREASED 184 0.0398
176 SKIN NECROSIS 206 0.0397
177 CREPITATIONS 118 0.0396
178 SPINAL FUSION SURGERY 160 0.0394
179 MYOSITIS 350 0.0390
180 ROAD TRAFFIC ACCIDENT 1631 0.0389
181 THERAPEUTIC RESPONSE UNEXPECTED 1730 0.0385
182 JOINT STIFFNESS 1009 0.0384
183 MIGRAINE 3660 0.0383
184 FOOT OPERATION 189 0.0382
185 BREATH SOUNDS ABNORMAL 188 0.0381
186 POOR QUALITY DRUG ADMINISTERED 246 0.0380
187 EPILEPSY 1160 0.0379
188 SLEEP DISORDER 2663 0.0377
189 TENDERNESS 390 0.0374
190 END STAGE RENAL DISEASE 681 0.0373
191 PHARYNGITIS 461 0.0371
192 FUNCTIONAL GASTROINTESTINAL DISORDER 127 0.0367
193 BODY TEMPERATURE DECREASED 361 0.0366
194 GASTROOESOPHAGEAL REFLUX DISEASE 2925 0.0363
195 ARTHRITIS 2858 0.0363
196 SHOULDER ARTHROPLASTY 97 0.0360
197 SENSITIVITY TO WEATHER CHANGE 189 0.0359
198 BLOOD PRESSURE SYSTOLIC INCREASED 699 0.0358
199 ILL-DEFINED DISORDER 2146 0.0353
200 OSTEOPOROSIS 1446 0.0351
201 INTENTIONAL PRODUCT USE ISSUE 3070 0.0350
202 DISABILITY 691 0.0349
203 ADVERSE REACTION 463 0.0349
204 INTERVERTEBRAL DISC DEGENERATION 323 0.0349
205 DRY MOUTH 2831 0.0349
206 UPPER GASTROINTESTINAL HAEMORRHAGE 586 0.0348
207 ABDOMINAL DISCOMFORT 5833 0.0347
208 BENIGN PROSTATIC HYPERPLASIA 178 0.0344
209 THERAPY NON-RESPONDER 1546 0.0344
210 DELIRIUM 1193 0.0343
211 PEPTIC ULCER 114 0.0343
212 BLOOD PRESSURE DIASTOLIC DECREASED 253 0.0342
213 LYMPHOEDEMA 237 0.0342
214 SPINAL OSTEOARTHRITIS 301 0.0342
215 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1644 0.0342
216 LIP SWELLING 1125 0.0337
217 PRODUCT USE ISSUE 6256 0.0333
218 PERIPHERAL SWELLING 5125 0.0332
219 LIVER DISORDER 1464 0.0330
220 STOMACH DISCOMFORT 170 0.0329
221 GENERAL SYMPTOM 244 0.0325
222 FOREIGN BODY 130 0.0324
223 DYSPEPSIA 3175 0.0322
224 BACK DISORDER 521 0.0320
225 THROMBOPHLEBITIS SUPERFICIAL 97 0.0320
226 ANOSMIA 463 0.0320
227 NODULE 415 0.0318
228 TREATMENT FAILURE 2613 0.0315
229 GENERAL PHYSICAL HEALTH DETERIORATION 3619 0.0312
230 EAR INFECTION 828 0.0311
231 HYPOAESTHESIA 4643 0.0310
232 DRUG-INDUCED LIVER INJURY 971 0.0309
233 EAR PAIN 599 0.0308
234 HEPATIC CIRRHOSIS 577 0.0307
235 SLEEP APNOEA SYNDROME 586 0.0307
236 SPINAL PAIN 359 0.0306
237 VAGINAL INFECTION 144 0.0306
238 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 524 0.0305
239 SINUSITIS 3102 0.0302
240 AMNESIA 1969 0.0302
241 GASTROINTESTINAL DISORDER 2710 0.0302
242 CUSHINGOID 97 0.0302
243 NORMAL NEWBORN 163 0.0300
244 TENDONITIS 457 0.0295
245 BONE LESION 106 0.0294
246 GASTRITIS EROSIVE 136 0.0291
247 ARTERIOSCLEROSIS CORONARY ARTERY 192 0.0290
248 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 193 0.0284
249 IMMUNODEFICIENCY 421 0.0282
250 VENTRICULAR TACHYCARDIA 462 0.0280
251 MATERNAL EXPOSURE DURING PREGNANCY 2492 0.0279
252 CONTUSION 2689 0.0279
253 ABDOMINAL PAIN UPPER 5743 0.0279
254 ANGIOEDEMA 1231 0.0278
255 MUSCLE TWITCHING 640 0.0277
256 JOINT INJURY 592 0.0277
257 SPINAL STENOSIS 113 0.0273
258 SKIN PAPILLOMA 109 0.0272
259 NERVE INJURY 301 0.0270
260 OESOPHAGEAL ULCER 104 0.0270
261 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1921 0.0270
262 URTICARIA 4520 0.0270
263 TOOTH INFECTION 352 0.0267
264 HYPERSENSITIVITY 4946 0.0266
265 HEPATITIS 680 0.0265
266 RED CELL DISTRIBUTION WIDTH INCREASED 110 0.0264
267 EPIGASTRIC DISCOMFORT 103 0.0263
268 EXTRA DOSE ADMINISTERED 1064 0.0262
269 SPUTUM DISCOLOURED 249 0.0262
270 INCORRECT PRODUCT ADMINISTRATION DURATION 565 0.0261
271 TUBULOINTERSTITIAL NEPHRITIS 488 0.0260
272 MUSCULAR WEAKNESS 2948 0.0259
273 ARTHRALGIA 10706 0.0257
274 TONGUE DISORDER 185 0.0255
275 TOOTHACHE 459 0.0253
276 FLANK PAIN 237 0.0253
277 MUSCULOSKELETAL DISCOMFORT 435 0.0252
278 BLOOD PRESSURE FLUCTUATION 606 0.0252
279 BRONCHIECTASIS 170 0.0252
280 DIVERTICULUM 179 0.0252
281 RENAL INJURY 748 0.0252
282 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 427 0.0251
283 GASTROINTESTINAL PAIN 275 0.0250
284 TRIGGER FINGER 102 0.0249
285 WEIGHT FLUCTUATION 260 0.0248
286 INFECTION 3569 0.0246
287 ATELECTASIS 238 0.0246
288 NASOPHARYNGITIS 4524 0.0245
289 TRANSIENT ISCHAEMIC ATTACK 823 0.0244
290 POST-TRAUMATIC STRESS DISORDER 163 0.0243
291 MEMORY IMPAIRMENT 3323 0.0242
292 NERVE COMPRESSION 223 0.0241
293 UVEITIS 327 0.0241
294 DIPLOPIA 616 0.0237
295 TENDON DISORDER 154 0.0236
296 HAEMATEMESIS 597 0.0235
297 HEPATIC ENZYME ABNORMAL 117 0.0234
298 FAECES DISCOLOURED 507 0.0234
299 SWOLLEN TONGUE 728 0.0233
300 ARTHRITIS INFECTIVE 108 0.0233
301 ALOPECIA 4566 0.0232
302 RESPIRATORY TRACT CONGESTION 368 0.0231
303 NEPHROLITHIASIS 1055 0.0230
304 CARPAL TUNNEL SYNDROME 319 0.0228
305 HYPERTENSION 4798 0.0226
306 MUSCULOSKELETAL DISORDER 430 0.0226
307 TINNITUS 1033 0.0225
308 DRUG EFFECT INCOMPLETE 814 0.0224
309 ECONOMIC PROBLEM 338 0.0223
310 PAIN OF SKIN 598 0.0222
311 RASH PAPULAR 497 0.0222
312 IMPAIRED WORK ABILITY 472 0.0221
313 MENISCUS INJURY 135 0.0219
314 PAIN IN EXTREMITY 6454 0.0219
315 GASTRITIS 576 0.0219
316 MEDICATION ERROR 1208 0.0217
317 DYSSTASIA 634 0.0217
318 CONFUSIONAL STATE 3496 0.0216
319 DRUG EFFECT DELAYED 98 0.0216
320 FEAR OF INJECTION 153 0.0214
321 INFLAMMATORY MARKER INCREASED 106 0.0214
322 RECTAL HAEMORRHAGE 916 0.0213
323 MELAENA 469 0.0213
324 PARAESTHESIA 3350 0.0213
325 ROTATOR CUFF SYNDROME 273 0.0212
326 HYPERCALCAEMIA 262 0.0212
327 CYSTITIS 675 0.0212
328 MUSCULOSKELETAL CHEST PAIN 328 0.0212
329 PRODUCT PHYSICAL CONSISTENCY ISSUE 117 0.0211
330 SINUS CONGESTION 284 0.0210
331 GASTROENTERITIS VIRAL 378 0.0209
332 HAEMORRHAGIC ANAEMIA 92 0.0209
333 HIATUS HERNIA 270 0.0208
334 MUSCLE STRAIN 180 0.0208
335 INTERVERTEBRAL DISC PROTRUSION 454 0.0207
336 SWELLING FACE 1352 0.0207
337 CHEST PAIN 3838 0.0207
338 TOXIC EPIDERMAL NECROLYSIS 314 0.0207
339 WEIGHT INCREASED 4630 0.0207
340 PAIN 12682 0.0206
341 SEASONAL ALLERGY 292 0.0206
342 CONCUSSION 159 0.0205
343 ABNORMAL LOSS OF WEIGHT 139 0.0204
344 HAEMATOCRIT DECREASED 403 0.0203
345 OSTEOPENIA 308 0.0203
346 UPPER RESPIRATORY TRACT INFECTION 930 0.0201
347 LIMB DISCOMFORT 622 0.0201
348 URINE ODOUR ABNORMAL 118 0.0200
349 DEPRESSION 4552 0.0200
350 MULTIPLE FRACTURES 328 0.0199
351 MICTURITION URGENCY 228 0.0199
352 BASAL CELL CARCINOMA 311 0.0199
353 MOUTH ULCERATION 420 0.0199
354 PREGNANCY 399 0.0199
355 BACK PAIN 4624 0.0199
356 ORAL DISCOMFORT 276 0.0198
357 ANAL ABSCESS 107 0.0198
358 TOOTH ABSCESS 202 0.0198
359 SKIN ULCER 512 0.0198
360 ANHEDONIA 520 0.0198
361 QUALITY OF LIFE DECREASED 265 0.0197
362 RENAL TUBULAR NECROSIS 192 0.0196
363 PHARYNGEAL SWELLING 191 0.0195
364 ASTHMA 2203 0.0195
365 DRUG ERUPTION 344 0.0194
366 DIVERTICULITIS 536 0.0193
367 PULMONARY CONGESTION 255 0.0193
368 ACUTE KIDNEY INJURY 2951 0.0193
369 PSORIASIS 2515 0.0192
370 GROIN PAIN 169 0.0192
371 SINUS HEADACHE 114 0.0192
372 OBSTRUCTIVE AIRWAYS DISORDER 213 0.0191
373 MOUTH SWELLING 109 0.0189
374 CONDITION AGGRAVATED 5715 0.0188
375 IRON DEFICIENCY ANAEMIA 173 0.0187
376 INSOMNIA 4977 0.0187
377 BODY TEMPERATURE INCREASED 380 0.0186
378 LIGAMENT SPRAIN 184 0.0186
379 DIABETIC NEUROPATHY 92 0.0186
380 MUSCLE SPASMS 3404 0.0185
381 GAIT DISTURBANCE 3549 0.0185
382 TOOTH DISORDER 411 0.0185
383 FREQUENT BOWEL MOVEMENTS 499 0.0185
384 GASTRIC DISORDER 631 0.0184
385 BONE DISORDER 332 0.0182
386 TENDON PAIN 137 0.0181
387 ANKLE FRACTURE 280 0.0181
388 BONE DENSITY DECREASED 565 0.0180
389 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 526 0.0179
390 FOOT FRACTURE 339 0.0179
391 BRONCHITIS 1323 0.0179
392 DEFORMITY 166 0.0177
393 EYE PRURITUS 596 0.0177
394 NEURALGIA 431 0.0177
395 VITAMIN D DEFICIENCY 172 0.0176
396 NEPHROPATHY 164 0.0175
397 HEART RATE DECREASED 614 0.0175
398 RESPIRATORY DISORDER 523 0.0175
399 FEELING HOT 1067 0.0174
400 PRODUCT ADMINISTRATION INTERRUPTED 136 0.0173
401 RENAL FAILURE 2299 0.0173
402 OEDEMA PERIPHERAL 2104 0.0172
403 VITAMIN D DECREASED 146 0.0171
404 RASH 7445 0.0171
405 KIDNEY INFECTION 335 0.0171
406 FEMUR FRACTURE 528 0.0170
407 PSYCHOLOGICAL TRAUMA 147 0.0170
408 FULL BLOOD COUNT ABNORMAL 180 0.0170
409 POOR QUALITY SLEEP 366 0.0170
410 ANAPHYLACTIC REACTION 939 0.0170
411 RENAL PAIN 180 0.0170
412 GALLBLADDER DISORDER 303 0.0170
413 EXPOSURE DURING PREGNANCY 1051 0.0169
414 PRODUCTIVE COUGH 803 0.0168
415 CHOLELITHIASIS 551 0.0168
416 RASH PRURITIC 908 0.0167
417 ANXIETY 4763 0.0167
418 RIB FRACTURE 344 0.0167
419 HYPERLIPIDAEMIA 199 0.0166
420 PHOTOPHOBIA 313 0.0166
421 NIGHTMARE 575 0.0166
422 DRUG SCREEN POSITIVE 131 0.0166
423 DISTURBANCE IN ATTENTION 890 0.0165
424 HYPERHIDROSIS 2108 0.0163
425 DIZZINESS 8146 0.0163
426 VOMITING 7678 0.0163
427 LOCALISED INFECTION 394 0.0163
428 OVARIAN CYST 161 0.0161
429 BLOOD IRON DECREASED 191 0.0161
430 GASTROINTESTINAL HAEMORRHAGE 1344 0.0161
431 ABDOMINAL PAIN 3717 0.0160
432 FLUID RETENTION 811 0.0159
433 MAJOR DEPRESSION 116 0.0159
434 HAEMATOCHEZIA 873 0.0158
435 BLOOD URINE PRESENT 300 0.0158
436 HEART RATE INCREASED 1564 0.0158
437 CYST 195 0.0157
438 COGNITIVE DISORDER 733 0.0157
439 INTENTIONAL PRODUCT MISUSE 1374 0.0157
440 WHITE BLOOD CELL COUNT INCREASED 602 0.0157
441 THROAT IRRITATION 703 0.0157
442 HAND FRACTURE 111 0.0157
443 DRUG INEFFECTIVE 20467 0.0155
444 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 852 0.0155
445 SEDATION 406 0.0155
446 MUSCLE SPASTICITY 190 0.0154
447 MALAISE 6753 0.0154
448 COMPLETED SUICIDE 1282 0.0154
449 PRODUCT USE IN UNAPPROVED INDICATION 3799 0.0153
450 INCREASED TENDENCY TO BRUISE 141 0.0153
451 HALLUCINATION 1153 0.0153
452 RED BLOOD CELL COUNT DECREASED 437 0.0153
453 DECREASED APPETITE 3539 0.0152
454 THERAPEUTIC RESPONSE DECREASED 922 0.0152
455 FATIGUE 11792 0.0151
456 BLOOD PRESSURE INCREASED 2300 0.0150
457 HEADACHE 9428 0.0150
458 EYE INFECTION 169 0.0150
459 CORONARY ARTERY DISEASE 452 0.0149
460 SPINAL DISORDER 141 0.0149
461 FEELING JITTERY 281 0.0147
462 POLYP 96 0.0146
463 ANGINA UNSTABLE 95 0.0146
464 PRURITUS GENERALISED 316 0.0146
465 NASAL CONGESTION 856 0.0146
466 HAEMORRHOIDS 284 0.0145
467 HYPERTRANSAMINASAEMIA 101 0.0145
468 TACHYCARDIA 1289 0.0145
469 HYPOKINESIA 210 0.0145
470 ABDOMINAL DISTENSION 1509 0.0144
471 UPPER-AIRWAY COUGH SYNDROME 119 0.0144
472 WEIGHT DECREASED 4032 0.0144
473 THERAPEUTIC RESPONSE SHORTENED 478 0.0144
474 OROPHARYNGEAL PAIN 1333 0.0144
475 MIDDLE INSOMNIA 268 0.0143
476 PARAESTHESIA ORAL 207 0.0143
477 INJECTION SITE REACTION 986 0.0143
478 HYPOAESTHESIA ORAL 216 0.0143
479 PRURITUS 5495 0.0143
480 FEELING DRUNK 106 0.0143
481 POSTOPERATIVE WOUND INFECTION 96 0.0142
482 BLINDNESS 579 0.0142
483 CELLULITIS 716 0.0142
484 POOR VENOUS ACCESS 147 0.0142
485 SENSORY LOSS 114 0.0141
486 VISUAL IMPAIRMENT 1752 0.0141
487 PALPITATIONS 1650 0.0141
488 ARTHROPOD BITE 104 0.0140
489 MULTIPLE ALLERGIES 110 0.0140
490 GOUT 251 0.0140
491 PYREXIA 4837 0.0140
492 DYSPNOEA EXERTIONAL 522 0.0138
493 RESTLESS LEGS SYNDROME 252 0.0138
494 NAUSEA 10963 0.0138
495 DECREASED ACTIVITY 149 0.0138
496 BLADDER DISORDER 137 0.0138
497 TENDON RUPTURE 170 0.0138
498 EATING DISORDER 293 0.0137
499 ADVERSE DRUG REACTION 1235 0.0137
500 HEPATIC STEATOSIS 256 0.0137
501 SKIN LACERATION 149 0.0137
502 SINUS DISORDER 271 0.0137
503 MOTOR DYSFUNCTION 139 0.0136
504 COLITIS ISCHAEMIC 92 0.0136
505 SKIN PLAQUE 115 0.0136
506 ORAL HERPES 266 0.0136
507 ASTHENIA 5122 0.0136
508 ADVERSE EVENT 1248 0.0135
509 HYPOCALCAEMIA 256 0.0135
510 ONYCHOCLASIS 93 0.0135
511 PNEUMONIA 4370 0.0135
512 DIARRHOEA 8710 0.0135
513 COORDINATION ABNORMAL 188 0.0135
514 OSTEOMYELITIS 244 0.0135
515 RHINORRHOEA 869 0.0134
516 SEPTIC SHOCK 585 0.0134
517 CHOLECYSTITIS 160 0.0134
518 SCAB 153 0.0134
519 LOWER GASTROINTESTINAL HAEMORRHAGE 99 0.0134
520 PHARYNGEAL OEDEMA 206 0.0134
521 FOOD ALLERGY 103 0.0133
522 RESPIRATORY RATE INCREASED 118 0.0133
523 PYELONEPHRITIS 115 0.0133
524 ORAL PAIN 297 0.0133
525 RENAL DISORDER 617 0.0132
526 MUSCLE TIGHTNESS 214 0.0132
527 SENSATION OF FOREIGN BODY 111 0.0132
528 MASS 184 0.0132
529 APHTHOUS ULCER 102 0.0131
530 CHOLECYSTECTOMY 150 0.0131
531 IMPAIRED GASTRIC EMPTYING 179 0.0131
532 PHOTOSENSITIVITY REACTION 216 0.0131
533 DEEP VEIN THROMBOSIS 848 0.0130
534 FEELING ABNORMAL 3125 0.0130
535 HYPOKALAEMIA 601 0.0130
536 OESOPHAGITIS 142 0.0130
537 TOOTH FRACTURE 143 0.0130
538 BIPOLAR DISORDER 141 0.0130
539 DYSPHONIA 752 0.0128
540 DYSPNOEA 7273 0.0128
541 LOCAL SWELLING 224 0.0128
542 FEELING COLD 357 0.0128
543 MOVEMENT DISORDER 411 0.0128
544 AFFECT LABILITY 123 0.0128
545 WRIST FRACTURE 153 0.0128
546 SKIN LESION 350 0.0127
547 LIMB INJURY 346 0.0127
548 THROAT TIGHTNESS 344 0.0127
549 DYSURIA 467 0.0127
550 INFLUENZA 1414 0.0127
551 ANURIA 109 0.0127
552 PLATELET COUNT INCREASED 165 0.0126
553 RHINITIS 102 0.0126
554 HAEMOGLOBIN DECREASED 1298 0.0126
555 MITRAL VALVE INCOMPETENCE 143 0.0126
556 EYE SWELLING 469 0.0126
557 RENAL CYST 100 0.0126
558 HYSTERECTOMY 109 0.0126
559 RESPIRATORY DEPRESSION 154 0.0126
560 UNDERDOSE 917 0.0125
561 HYPERAESTHESIA 103 0.0125
562 PRODUCT PRESCRIBING ISSUE 273 0.0125
563 POISONING 157 0.0125
564 FALL 4146 0.0124
565 DERMATITIS 260 0.0124
566 DIZZINESS POSTURAL 120 0.0124
567 RENAL FAILURE ACUTE 525 0.0124
568 HUNGER 172 0.0123
569 HEPATOMEGALY 121 0.0123
570 TEMPERATURE INTOLERANCE 127 0.0123
571 SKIN INFECTION 138 0.0123
572 INTENTIONAL OVERDOSE 786 0.0122
573 RESPIRATORY TRACT INFECTION 319 0.0122
574 CONJUNCTIVITIS 226 0.0122
575 PRODUCT PRESCRIBING ERROR 289 0.0121
576 HERPES ZOSTER 697 0.0121
577 FEEDING DISORDER 245 0.0121
578 INTERNAL HAEMORRHAGE 138 0.0121
579 HOT FLUSH 909 0.0120
580 PANCREATITIS 637 0.0120
581 SCAR 206 0.0120
582 INCONTINENCE 127 0.0120
583 INITIAL INSOMNIA 123 0.0120
584 OBSESSIVE-COMPULSIVE DISORDER 96 0.0120
585 DYSMENORRHOEA 158 0.0119
586 IMMUNOSUPPRESSION 105 0.0119
587 CHOKING 231 0.0118
588 GINGIVAL PAIN 94 0.0118
589 COLITIS ULCERATIVE 527 0.0118
590 CONSTIPATION 2567 0.0118
591 MUSCLE RIGIDITY 140 0.0117
592 TRICUSPID VALVE INCOMPETENCE 93 0.0117
593 HEART RATE IRREGULAR 264 0.0117
594 BURNING SENSATION 819 0.0117
595 LABORATORY TEST ABNORMAL 344 0.0116
596 IMPAIRED QUALITY OF LIFE 166 0.0115
597 URINARY TRACT INFECTION 1958 0.0115
598 PAIN IN JAW 325 0.0115
599 CARDIOMEGALY 141 0.0115
600 DIARRHOEA HAEMORRHAGIC 107 0.0114
601 CARDIAC MURMUR 99 0.0114
602 NEUTROPHIL COUNT INCREASED 117 0.0114
603 INFLUENZA LIKE ILLNESS 940 0.0114
604 SOMNOLENCE 2298 0.0114
605 ANAPHYLACTIC SHOCK 294 0.0114
606 ORAL CANDIDIASIS 150 0.0114
607 HERNIA 220 0.0114
608 PHARYNGITIS STREPTOCOCCAL 123 0.0114
609 PULMONARY MASS 169 0.0113
610 EUPHORIC MOOD 116 0.0113
611 DECREASED IMMUNE RESPONSIVENESS 111 0.0113
612 VIRAL INFECTION 374 0.0112
613 OXYGEN SATURATION DECREASED 631 0.0112
614 PRODUCT PHYSICAL ISSUE 226 0.0112
615 SNEEZING 251 0.0112
616 SCRATCH 118 0.0112
617 EYE PAIN 630 0.0112
618 BRAIN FOG 175 0.0112
619 SUICIDE ATTEMPT 675 0.0111
620 SINUS TACHYCARDIA 158 0.0111
621 NOCTURIA 135 0.0111
622 CHROMATURIA 250 0.0111
623 LIVER FUNCTION TEST ABNORMAL 321 0.0110
624 DENTAL CARIES 121 0.0109
625 BLOOD UREA INCREASED 183 0.0109
626 ANGINA PECTORIS 313 0.0109
627 COLD SWEAT 192 0.0109
628 APHONIA 152 0.0109
629 HIDRADENITIS 99 0.0108
630 DEHYDRATION 1444 0.0108
631 BLOOD PRESSURE ABNORMAL 215 0.0108
632 COUGH 3027 0.0108
633 ALANINE AMINOTRANSFERASE INCREASED 662 0.0108
634 MYALGIA 1833 0.0108
635 SEROTONIN SYNDROME 207 0.0108
636 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 561 0.0107
637 OROPHARYNGEAL DISCOMFORT 97 0.0107
638 BONE PAIN 629 0.0107
639 DRUG TOXICITY 146 0.0107
640 EAR DISCOMFORT 110 0.0107
641 SENSORY DISTURBANCE 172 0.0107
642 DERMATITIS CONTACT 122 0.0107
643 RASH MACULAR 374 0.0107
644 CHEST DISCOMFORT 1095 0.0107
645 SKIN DISORDER 356 0.0107
646 RASH ERYTHEMATOUS 510 0.0107
647 PRODUCT USE COMPLAINT 168 0.0107
648 PETECHIAE 111 0.0106
649 RESPIRATORY ARREST 292 0.0106
650 DYSARTHRIA 398 0.0106
651 BALANCE DISORDER 913 0.0106
652 UPPER LIMB FRACTURE 210 0.0105
653 DEPRESSED MOOD 556 0.0105
654 DRUG PRESCRIBING ERROR 202 0.0105
655 HEMIPARESIS 178 0.0105
656 LOSS OF CONSCIOUSNESS 1346 0.0105
657 HYPERKALAEMIA 368 0.0105
658 PERIPHERAL COLDNESS 144 0.0105
659 SUICIDAL IDEATION 958 0.0105
660 OFF LABEL USE 9151 0.0104
661 SKIN FISSURES 204 0.0104
662 SKIN HAEMORRHAGE 154 0.0104
663 VERTIGO 633 0.0104
664 CATARACT 615 0.0103
665 BLOOD TEST ABNORMAL 145 0.0103
666 METABOLIC ACIDOSIS 330 0.0103
667 CANDIDA INFECTION 174 0.0103
668 ACCIDENT 123 0.0103
669 DEAFNESS 269 0.0103
670 DRY EYE 513 0.0103
671 BLOOD TRIGLYCERIDES INCREASED 181 0.0102
672 POLLAKIURIA 427 0.0102
673 INFLAMMATORY BOWEL DISEASE 100 0.0102
674 THYROID DISORDER 157 0.0102
675 HEAD DISCOMFORT 180 0.0102
676 STEVENS-JOHNSON SYNDROME 225 0.0101
677 COAGULOPATHY 168 0.0101
678 DRUG EFFECT LESS THAN EXPECTED 149 0.0100
679 ACUTE MYOCARDIAL INFARCTION 296 0.0100
680 IMPAIRED DRIVING ABILITY 114 0.0100
681 SKIN DISCOLOURATION 460 0.0100
682 PRESYNCOPE 243 0.0100
683 ABDOMINAL PAIN LOWER 252 0.0100
684 GINGIVAL BLEEDING 136 0.0100
685 ASPIRATION 109 0.0099
686 URINARY RETENTION 332 0.0099
687 BREAST PAIN 106 0.0099
688 FLATULENCE 563 0.0099
689 URINARY INCONTINENCE 294 0.0099
690 BODY HEIGHT DECREASED 106 0.0099
691 POST PROCEDURAL COMPLICATION 190 0.0099
692 LACERATION 93 0.0099
693 ARTERIOSCLEROSIS 93 0.0099
694 DIABETES MELLITUS 753 0.0099
695 PLEURAL EFFUSION 601 0.0099
696 FEAR 265 0.0098
697 LETHARGY 566 0.0098
698 PRODUCT TASTE ABNORMAL 133 0.0098
699 BONE LOSS 147 0.0098
700 PULMONARY EMBOLISM 929 0.0098
701 AGITATION 716 0.0097
702 VISION BLURRED 1338 0.0097
703 PRODUCT QUALITY ISSUE 1320 0.0097
704 DERMATITIS ALLERGIC 122 0.0097
705 PALLOR 263 0.0097
706 HYPERSOMNIA 277 0.0097
707 GASTROENTERITIS 141 0.0097
708 PANIC ATTACK 352 0.0096
709 CHILLS 1132 0.0096
710 PROSTATIC SPECIFIC ANTIGEN INCREASED 133 0.0096
711 MALIGNANT MELANOMA 129 0.0096
712 FLUSHING 974 0.0096
713 PELVIC PAIN 174 0.0096
714 FRACTURE 181 0.0096
715 HYPOPHAGIA 243 0.0095
716 SPINAL OPERATION 117 0.0095
717 ACTIVITIES OF DAILY LIVING IMPAIRED 188 0.0095
718 TOXICITY TO VARIOUS AGENTS 1601 0.0095
719 FUNGAL INFECTION 316 0.0095
720 RASH GENERALISED 245 0.0095
721 INTESTINAL PERFORATION 106 0.0094
722 ERYTHEMA 1941 0.0094
723 BLOOD CALCIUM DECREASED 106 0.0094
724 EPISTAXIS 705 0.0094
725 MOOD SWINGS 299 0.0094
726 DISORIENTATION 371 0.0094
727 MYOCARDIAL INFARCTION 1627 0.0093
728 MUSCLE ATROPHY 118 0.0093
729 CENTRAL NERVOUS SYSTEM LESION 127 0.0092
730 HAIR COLOUR CHANGES 115 0.0092
731 HYPOTHYROIDISM 295 0.0092
732 ANGER 311 0.0092
733 IMMUNE SYSTEM DISORDER 121 0.0092
734 ASPARTATE AMINOTRANSFERASE INCREASED 487 0.0092
735 NEUROPATHY PERIPHERAL 871 0.0091
736 EYE DISORDER 301 0.0091
737 RETCHING 194 0.0091
738 HYPOTENSION 1824 0.0091
739 NEPHROPATHY TOXIC 102 0.0091
740 EYE DISCHARGE 94 0.0090
741 COVID-19 1584 0.0090
742 INTERSTITIAL LUNG DISEASE 437 0.0090
743 SECRETION DISCHARGE 113 0.0090
744 DYSPHAGIA 853 0.0090
745 STAPHYLOCOCCAL INFECTION 296 0.0090
746 HAIR TEXTURE ABNORMAL 120 0.0090
747 EMOTIONAL DISTRESS 1086 0.0090
748 DYSGEUSIA 666 0.0090
749 MULTIPLE SCLEROSIS 426 0.0089
750 TREMOR 1476 0.0089
751 DRUG INTERACTION 1409 0.0089
752 ATAXIA 105 0.0088
753 ABSCESS 141 0.0088
754 MENTAL STATUS CHANGES 245 0.0088
755 MYDRIASIS 113 0.0088
756 MENTAL DISORDER 383 0.0088
757 GLOMERULAR FILTRATION RATE DECREASED 108 0.0088
758 BLOOD PRESSURE DECREASED 583 0.0088
759 SPEECH DISORDER 459 0.0088
760 PARANOIA 151 0.0088
761 BLOOD POTASSIUM DECREASED 262 0.0087
762 LYMPHADENOPATHY 308 0.0087
763 BLOOD CREATININE INCREASED 567 0.0087
764 NERVOUSNESS 452 0.0086
765 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1559 0.0086
766 RENAL IMPAIRMENT 726 0.0086
767 PNEUMOTHORAX 137 0.0086
768 HEAD INJURY 273 0.0086
769 THIRST 154 0.0086
770 SKIN REACTION 121 0.0086
771 SPINAL FRACTURE 172 0.0086
772 MADAROSIS 99 0.0085
773 SURGERY 500 0.0085
774 LEUKOCYTOSIS 154 0.0085
775 JAUNDICE 228 0.0085
776 SYNCOPE 847 0.0085
777 INCORRECT DOSE ADMINISTERED 1930 0.0084
778 INTENTIONAL SELF-INJURY 170 0.0084
779 PROCEDURAL PAIN 233 0.0084
780 CORONARY ARTERY OCCLUSION 115 0.0084
781 LYMPHOCYTE COUNT DECREASED 148 0.0084
782 THERAPY PARTIAL RESPONDER 130 0.0083
783 DYSKINESIA 338 0.0083
784 DRY SKIN 1110 0.0083
785 BACTERIAL INFECTION 155 0.0083
786 MYOCARDIAL ISCHAEMIA 94 0.0083
787 OCULAR HYPERAEMIA 391 0.0082
788 SMALL INTESTINAL OBSTRUCTION 100 0.0081
789 ACUTE HEPATIC FAILURE 111 0.0081
790 ILLNESS 835 0.0081
791 PARALYSIS 116 0.0081
792 APHASIA 242 0.0080
793 UNEVALUABLE EVENT 606 0.0080
794 HAEMATURIA 274 0.0080
795 EYELID OEDEMA 93 0.0080
796 ANAEMIA 1520 0.0080
797 SARS-COV-2 TEST POSITIVE 105 0.0079
798 EYE HAEMORRHAGE 106 0.0079
799 IRRITABILITY 475 0.0079
800 ABNORMAL DREAMS 217 0.0079
801 GENERALISED OEDEMA 97 0.0078
802 DRUG EFFECT DECREASED 422 0.0078
803 BLOOD COUNT ABNORMAL 118 0.0078
804 TREATMENT NONCOMPLIANCE 425 0.0078
805 TOOTH LOSS 161 0.0078
806 INFUSION SITE PAIN 100 0.0078
807 PRODUCT DOSE OMISSION IN ERROR 219 0.0077
808 PULMONARY OEDEMA 342 0.0076
809 MENTAL IMPAIRMENT 185 0.0076
810 CRYING 277 0.0076
811 DEPRESSED LEVEL OF CONSCIOUSNESS 301 0.0076
812 LUNG INFECTION 118 0.0076
813 HIP FRACTURE 244 0.0076
814 CARDIO-RESPIRATORY ARREST 315 0.0075
815 HAEMOPTYSIS 210 0.0075
816 MULTIPLE SCLEROSIS RELAPSE 513 0.0075
817 MOOD ALTERED 204 0.0075
818 INSURANCE ISSUE 114 0.0074
819 ABASIA 183 0.0074
820 LACRIMATION INCREASED 223 0.0074
821 BLINDNESS UNILATERAL 104 0.0074
822 ECZEMA 385 0.0073
823 THROMBOSIS 591 0.0073
824 DIABETES MELLITUS INADEQUATE CONTROL 130 0.0073
825 BEDRIDDEN 96 0.0073
826 BLOOD POTASSIUM INCREASED 118 0.0073
827 EMOTIONAL DISORDER 223 0.0072
828 NO ADVERSE EVENT 1306 0.0072
829 PANCREATITIS ACUTE 162 0.0072
830 RASH MACULO-PAPULAR 160 0.0072
831 ERUCTATION 138 0.0071
832 AGEUSIA 177 0.0071
833 PNEUMONIA ASPIRATION 177 0.0071
834 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 503 0.0071
835 INJECTION SITE BRUISING 564 0.0071
836 INJECTION SITE WARMTH 145 0.0070
837 CLOSTRIDIUM DIFFICILE INFECTION 153 0.0070
838 RESTLESSNESS 255 0.0070
839 OVERDOSE 1503 0.0070
840 BLOOD ALKALINE PHOSPHATASE INCREASED 173 0.0070
841 HAEMORRHAGE 727 0.0069
842 BLOOD SODIUM DECREASED 131 0.0069
843 INTENTIONAL DOSE OMISSION 198 0.0069
844 EYE IRRITATION 396 0.0069
845 SHOCK 157 0.0068
846 MANIA 112 0.0068
847 INJECTION SITE PRURITUS 454 0.0068
848 ATRIAL FIBRILLATION 660 0.0068
849 FACE OEDEMA 114 0.0068
850 PROTEINURIA 128 0.0067
851 COLITIS 255 0.0067
852 SKIN EXFOLIATION 565 0.0067
853 RHABDOMYOLYSIS 279 0.0067
854 VAGINAL HAEMORRHAGE 286 0.0066
855 PNEUMONITIS 179 0.0066
856 OSTEONECROSIS 215 0.0065
857 ACCIDENTAL OVERDOSE 239 0.0065
858 COMA 311 0.0065
859 APATHY 95 0.0065
860 HEPATOTOXICITY 145 0.0065
861 THINKING ABNORMAL 121 0.0065
862 UNRESPONSIVE TO STIMULI 167 0.0065
863 MENORRHAGIA 127 0.0065
864 WRONG TECHNIQUE IN DRUG USAGE PROCESS 234 0.0064
865 INJECTION SITE URTICARIA 158 0.0064
866 INTERNATIONAL NORMALISED RATIO INCREASED 183 0.0064
867 PRODUCT DOSE OMISSION 417 0.0064
868 DELUSION 99 0.0064
869 CARDIOMYOPATHY 94 0.0064
870 MUCOSAL INFLAMMATION 166 0.0063
871 SEPSIS 707 0.0063
872 MULTI-ORGAN FAILURE 109 0.0063
873 FOETAL EXPOSURE DURING PREGNANCY 511 0.0063
874 HYPERGLYCAEMIA 229 0.0063
875 LYMPHOMA 97 0.0063
876 TRANSAMINASES INCREASED 139 0.0062
877 INJECTION SITE ERYTHEMA 775 0.0062
878 HYPOXIA 220 0.0062
879 INTESTINAL OBSTRUCTION 235 0.0062
880 GLAUCOMA 120 0.0062
881 INJECTION SITE RASH 190 0.0062
882 ERECTILE DYSFUNCTION 159 0.0062
883 LACTIC ACIDOSIS 200 0.0062
884 WHITE BLOOD CELL COUNT DECREASED 668 0.0062
885 PRODUCT ADMINISTRATION ERROR 124 0.0061
886 HALLUCINATION, VISUAL 129 0.0061
887 RESPIRATORY FAILURE 445 0.0061
888 HYPONATRAEMIA 343 0.0061
889 PSYCHOMOTOR HYPERACTIVITY 101 0.0061
890 CARDIAC ARREST 498 0.0060
891 THERAPY CESSATION 309 0.0060
892 BLOOD BILIRUBIN INCREASED 162 0.0060
893 HAEMATOMA 155 0.0060
894 INCREASED APPETITE 113 0.0059
895 INJECTION SITE SWELLING 452 0.0059
896 SKIN CANCER 127 0.0059
897 BLOOD GLUCOSE INCREASED 1104 0.0059
898 PULMONARY HYPERTENSION 122 0.0059
899 PERICARDIAL EFFUSION 134 0.0058
900 METASTASES TO BONE 95 0.0058
901 CIRCULATORY COLLAPSE 98 0.0057
902 CARDIAC FAILURE CONGESTIVE 460 0.0057
903 CEREBROVASCULAR ACCIDENT 968 0.0057
904 ORTHOSTATIC HYPOTENSION 99 0.0057
905 INJECTION SITE PAIN 1738 0.0057
906 EXTRAPYRAMIDAL DISORDER 140 0.0056
907 SEIZURE 649 0.0056
908 DRUG LEVEL INCREASED 92 0.0056
909 THROMBOCYTOPENIA 621 0.0055
910 CARDIAC DISORDER 519 0.0055
911 LEUKOPENIA 277 0.0055
912 NERVOUS SYSTEM DISORDER 171 0.0055
913 WITHDRAWAL SYNDROME 230 0.0055
914 HEPATIC FAILURE 165 0.0055
915 NEEDLE ISSUE 159 0.0055
916 VISUAL ACUITY REDUCED 181 0.0054
917 INJECTION SITE MASS 200 0.0054
918 CONVULSION 307 0.0054
919 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 138 0.0054
920 AMENORRHOEA 94 0.0054
921 ABNORMAL BEHAVIOUR 211 0.0053
922 HYPOGLYCAEMIA 258 0.0053
923 EOSINOPHILIA 93 0.0053
924 MULTIPLE ORGAN DYSFUNCTION SYNDROME 149 0.0053
925 ACUTE RESPIRATORY FAILURE 101 0.0052
926 PLATELET COUNT DECREASED 559 0.0052
927 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 175 0.0052
928 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1049 0.0052
929 PERITONITIS 107 0.0052
930 INTENTIONAL DRUG MISUSE 108 0.0052
931 AGGRESSION 256 0.0051
932 INJECTION SITE HAEMORRHAGE 406 0.0051
933 ALTERED STATE OF CONSCIOUSNESS 110 0.0051
934 PRODUCT DOSE OMISSION ISSUE 1476 0.0050
935 PSYCHOTIC DISORDER 147 0.0050
936 CARDIOVASCULAR DISORDER 126 0.0050
937 DRUG ADMINISTRATION ERROR 152 0.0049
938 DRUG DOSE OMISSION 817 0.0049
939 RESPIRATORY DISTRESS 136 0.0049
940 ELECTROCARDIOGRAM QT PROLONGED 175 0.0049
941 ABORTION SPONTANEOUS 194 0.0048
942 DRUG ABUSE 397 0.0048
943 HYPOACUSIS 205 0.0048
944 HOSPITALISATION 730 0.0047
945 NEOPLASM MALIGNANT 314 0.0047
946 ARRHYTHMIA 222 0.0047
947 PRODUCT SUBSTITUTION ISSUE 269 0.0047
948 ENCEPHALOPATHY 114 0.0046
949 BLOOD CREATINE PHOSPHOKINASE INCREASED 132 0.0046
950 DEMENTIA 127 0.0045
951 DISEASE RECURRENCE 216 0.0045
952 ACNE 344 0.0045
953 PRODUCT AVAILABILITY ISSUE 101 0.0044
954 ASCITES 130 0.0044
955 THERAPY INTERRUPTED 316 0.0044
956 DIABETIC KETOACIDOSIS 104 0.0043
957 BRADYCARDIA 225 0.0042
958 BLOOD GLUCOSE DECREASED 203 0.0042
959 CEREBRAL HAEMORRHAGE 150 0.0042
960 OSTEONECROSIS OF JAW 103 0.0042
961 FEBRILE NEUTROPENIA 269 0.0041
962 SKIN IRRITATION 185 0.0040
963 SKIN BURNING SENSATION 284 0.0040
964 DISEASE PROGRESSION 461 0.0039
965 GLYCOSYLATED HAEMOGLOBIN INCREASED 96 0.0038
966 DEVICE ISSUE 331 0.0037
967 TARDIVE DYSKINESIA 101 0.0036
968 HEPATIC FUNCTION ABNORMAL 133 0.0036
969 PANCYTOPENIA 199 0.0036
970 DRUG DEPENDENCE 571 0.0035
971 PHARMACEUTICAL PRODUCT COMPLAINT 92 0.0035
972 NEUTROPHIL COUNT DECREASED 142 0.0035
973 NEOPLASM PROGRESSION 120 0.0034
974 MALIGNANT NEOPLASM PROGRESSION 344 0.0034
975 LUNG NEOPLASM MALIGNANT 138 0.0034
976 BREAST CANCER 310 0.0033
977 NEUTROPENIA 447 0.0033
978 DEVICE MALFUNCTION 222 0.0032
979 PLASMA CELL MYELOMA 121 0.0031
980 CARDIAC FAILURE 248 0.0031
981 DRUG WITHDRAWAL SYNDROME 261 0.0030
982 DERMATITIS ATOPIC 147 0.0028
983 DRUG EXPOSURE DURING PREGNANCY 92 0.0027
984 ACCIDENTAL EXPOSURE TO PRODUCT 277 0.0027
985 PRODUCT ADHESION ISSUE 93 0.0026
986 DEVICE BREAKAGE 100 0.0025
987 DEVICE DISLOCATION 106 0.0024
988 DEATH 2071 0.0024
989 PROSTATE CANCER 136 0.0017
990 DEVICE DIFFICULT TO USE 92 0.0014
991 PRODUCT STORAGE ERROR 111 0.0013